Corticosteroids in combination therapy for multiple sclerosis
Cohen, J.A.
LANCET. Neurology 8(6): 502-503
2009
ISSN/ISBN: 1474-4422 PMID: 19409855 DOI: 10.1016/s1474-4422(09)70089-4
Accession: 052366105
Full Text Article emailed within 0-6 h: $19.90
Related References
Voltz, R.; Hohlfeld, R. 1992: Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids Der Nervenarzt 63(12): 773-775Gold, R. 1999: High dosage corticosteroids: in multiple sclerosis pulse therapy is of value MMW Fortschritte der Medizin 141(25): 76-77
Voltz, R.; Hohlfeld, R. 1992: Current treatment of multiple sclerosis High-dosage intravenous therapy with corticosteroids Nervenarzt 63(12): 773-775
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2012: Treatment of Exacerbations of Multiple Sclerosis without the Use of Corticosteroids The Role of Metabolic and Antioxidant Therapy Neuroscience and Behavioral Physiology 42(2): 123-127
Bisaga, G.N.; Odinak, M.M.; Boĭko, A.N.; Mel'nik, I.B.; Popova, N.F. 2011: Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(2): 44-48
Henze, T.; Rieckmann, P.; Toyka, K.V. 2006: Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society European Neurology 56(2): 78-105
Milo, R.; Panitch, H. 2011: Combination therapy in multiple sclerosis Journal of Neuroimmunology 231(1-2): 23-31
Conway, D.; Cohen, J.A. 2010: Combination therapy in multiple sclerosis LANCET. Neurology 9(3): 299-308
Gonsette, R.E. 2004: Combination therapy for multiple sclerosis International Ms Journal 11(1): 10-21
Tullman, M.J.; Lublin, F.D. 2005: Combination therapy in multiple sclerosis Current Neurology and Neuroscience Reports 5(3): 245-248
Fernández, O. 2007: Combination therapy in multiple sclerosis Journal of the Neurological Sciences 259(1-2): 95-103
Lublin, F.D.; Reingold, S.C. 1998: Combination therapy for treatment of multiple sclerosis Annals of Neurology 44(1): 7-9
Kieseier, B.C.; Stüve, O. 2011: Multiple sclerosis: combination therapy in MS--still a valid strategy Nature Reviews. Neurology 7(12): 659-660
Cross, A.H.; Klein, R.S.; Piccio, L. 2012: Rituximab combination therapy in relapsing multiple sclerosis Therapeutic Advances in Neurological Disorders 5(6): 311-319
Mäurer, M.; Rieckmann, P. 2000: Relapsing-remitting multiple sclerosis: what is the potential for combination therapy? Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 13(3): 149-158
Jeffery, D.R. 2004: Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosis Neurology 63(12 Suppl 6): S41-S46
Weinstock-Guttman, B.; Bakshi, R. 2004: Combination therapy for multiple sclerosis: the treatment strategy of the future? Cns Drugs 18(12): 777-792
Stuart, W.H. 2007: Combination therapy for the treatment of multiple sclerosis: challenges and opportunities Current Medical Research and Opinion 23(6): 1199-1208
Faraji, F.; Hashemi, M.; Ghiasabadi, A.; Davoudian, S.; Talaie, A.; Ganji, A.; Mosayebi, G. 2019: Combination therapy with interferon beta-1a and sesame oil in multiple sclerosis Complementary Therapies in Medicine 45: 275-279
Carbonella, A.; Berardi, G.; Petricca, L.; Biscetti, F.; Alivernini, S.; Bosello, S.L.; Fedele, A.L.; Ferraccioli, G.; Gremese, E. 2016: Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone Journal of the American Geriatrics Society 64(3): 672